COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | COM | 00287Y109 | 889,866 | 14,373,538 | SH | | SOLE | | 14,373,538 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 795,813 | 24,516,738 | SH | | SOLE | | 24,516,738 | 0 | 0 |
Acceleron Pharma Inc. | COM | 00434H108 | 977 | 28,765 | SH | | SOLE | | 28,765 | 0 | 0 |
Achaogen, Inc. | COM | 004449104 | 379 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 19,309 | 2,475,515 | SH | | SOLE | | 2,475,515 | 0 | 0 |
Acorda Therapeutics, Inc. | COM | 00484M106 | 93,376 | 3,661,082 | SH | | SOLE | | 3,661,082 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 2,614 | 172,630 | SH | | SOLE | | 172,630 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 815 | 100,000 | SH | | SOLE | | 600,000 | 0 | 0 |
Advanced Accelerator Applications S.A. | SPONSORED ADR | 00790T100 | 25,188 | 833,089 | SH | | SOLE | | 1,666,178 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 1,965 | 404,230 | SH | | SOLE | | 404,230 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 5,269 | 299,356 | SH | | SOLE | | 299,356 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 992 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 8,711 | 207,915 | SH | | SOLE | | 207,915 | 0 | 0 |
Aimmune Therapeutics, Inc. | COM | 00900T107 | 7,292 | 673,908 | SH | | SOLE | | 673,908 | 0 | 0 |
Akari Therapeutics plc | SPONSORED ADR | 00972G108 | 6,703 | 496,901 | SH | | SOLE | | 49,690,100 | 0 | 0 |
Alcobra Ltd. | SHS | M2239P109 | 10,490 | 2,336,359 | SH | | SOLE | | 2,336,359 | 0 | 0 |
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 5,427 | 217,328 | SH | | SOLE | | 217,328 | 0 | 0 |
Aldeyra Therapeutics, Inc. | COM | 01438T106 | 808 | 142,000 | SH | | SOLE | | 142,000 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 763,995 | 6,543,295 | SH | | SOLE | | 6,543,295 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 10,816 | 250,251 | SH | | SOLE | | 250,251 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 629 | 11,340 | SH | | SOLE | | 11,340 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 1,732 | 801,860 | SH | | SOLE | | 801,860 | 0 | 0 |
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 51,321 | 7,752,487 | SH | | SOLE | | 7,752,487 | 0 | 0 |
Arbutus Biopharma Corporation | COM | 03879J100 | 628 | 180,582 | SH | | SOLE | | 180,582 | 0 | 0 |
Array BioPharma Inc. | COM | 04269X105 | 15,346 | 4,310,666 | SH | | SOLE | | 4,310,666 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | COM | 04280A100 | 5,371 | 1,009,509 | SH | | SOLE | | 1,009,509 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 9,893 | 745,521 | SH | | SOLE | | 745,521 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 1,388 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 2,120 | 711,499 | SH | | SOLE | | 711,499 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 56,998 | 1,912,680 | SH | | SOLE | | 24,864,840 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 63,059 | 4,865,647 | SH | | SOLE | | 4,865,647 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 42,630 | 15,010,534 | SH | | SOLE | | 15,010,534 | 0 | 0 |
BioDelivery Sciences International, Inc. | COM | 09060J106 | 496 | 210,021 | SH | | SOLE | | 210,021 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 373,944 | 4,806,483 | SH | | SOLE | | 4,806,483 | 0 | 0 |
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 9 | 20,084 | SH | | SOLE | | 20,084 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 12,725 | 293,943 | SH | | SOLE | | 293,943 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 3,637 | 5,122,153 | SH | | SOLE | | 5,122,153 | 0 | 0 |
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,330 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 84,572 | 13,553,275 | SH | | SOLE | | 13,553,275 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 220 | 49,064 | SH | | SOLE | | 49,064 | 0 | 0 |
Chimerix, Inc. | COM | 16934W106 | 453 | 115,216 | SH | | SOLE | | 115,216 | 0 | 0 |
Concert Pharmaceuticals, Inc. | COM | 206022105 | 5,279 | 470,058 | SH | | SOLE | | 470,058 | 0 | 0 |
Curis, Inc. | COM | 231269101 | 3,119 | 1,999,303 | SH | | SOLE | | 1,999,303 | 0 | 0 |
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 83 | 13,253 | SH | | SOLE | | 13,253 | 0 | 0 |
CytRx Corporation | COM PAR $.001 | 232828509 | 1,472 | 659,995 | SH | | SOLE | | 659,995 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 179,722 | 5,509,560 | SH | | SOLE | | 2,754,780 | 0 | 0 |
Derma Sciences, Inc. | COM PAR $.01 | 249827502 | 14,784 | 3,752,390 | SH | | SOLE | | 3,752,390 | 0 | 0 |
Dermira, Inc. | COM | 24983L104 | 9,548 | 326,428 | SH | | SOLE | | 326,428 | 0 | 0 |
Dimension Therapeutics, Inc. | COM | 25433V105 | 7,511 | 1,251,881 | SH | | SOLE | | 1,251,881 | 0 | 0 |
Dynavax Technologies Corporation | COM NEW | 268158201 | 1,094 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Enanta Pharmaceuticals, Inc. | COM | 29251M106 | 1,662 | 75,357 | SH | | SOLE | | 75,357 | 0 | 0 |
Endocyte, Inc. | COM | 29269A102 | 3,629 | 1,130,577 | SH | | SOLE | | 1,130,577 | 0 | 0 |
Epizyme, Inc. | COM | 29428V104 | 2,381 | 232,481 | SH | | SOLE | | 232,481 | 0 | 0 |
Exelixis, Inc. | COM | 30161Q104 | 20,150 | 2,580,000 | SH | | SOLE | | 2,580,000 | 0 | 0 |
Five Prime Therapeutics, Inc. | COM | 33830X104 | 796 | 19,247 | SH | | SOLE | | 19,247 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 14,235 | 2,241,702 | SH | | SOLE | | 2,241,702 | 0 | 0 |
Foundation Medicine, Inc. | COM | 350465100 | 390 | 20,892 | SH | | SOLE | | 20,892 | 0 | 0 |
Galapagos NV | SPONSORED ADR | 36315X101 | 14,416 | 259,894 | SH | | SOLE | | 259,894 | 0 | 0 |
Genomic Health, Inc. | COM | 37244C101 | 353,955 | 13,668,866 | SH | | SOLE | | 13,668,866 | 0 | 0 |
GlycoMimetics, Inc. | COM | 38000Q102 | 2,772 | 381,235 | SH | | SOLE | | 381,235 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 1,374 | 15,000 | SH | | SOLE | | 180,000 | 0 | 0 |
Halozyme Therapeutics, Inc. | COM | 40637H109 | 15,862 | 1,838,057 | SH | | SOLE | | 1,838,057 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 51,573 | 2,857,250 | SH | | SOLE | | 2,857,250 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 10,711 | 7,000,977 | SH | | SOLE | | 7,000,977 | 0 | 0 |
Ignyta, Inc. | COM | 451731103 | 3,095 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Immune Design Corp. | COM | 45252L103 | 1,215 | 148,937 | SH | | SOLE | | 148,937 | 0 | 0 |
ImmunoGen, Inc. | COM | 45253H101 | 9,287 | 3,015,353 | SH | | SOLE | | 3,015,353 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 1,879,426 | 23,498,697 | SH | | SOLE | | 23,498,697 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 14,790 | 1,500,000 | SH | | SOLE | | 1,500,000 | 0 | 0 |
Intellia Therapeutics, Inc. | COM | 45826J105 | 22,676 | 1,062,120 | SH | | SOLE | | 1,062,120 | 0 | 0 |
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 23,648 | 609,166 | SH | | SOLE | | 609,166 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 48,441 | 6,554,967 | SH | | SOLE | | 6,554,967 | 0 | 0 |
InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | 2,312 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | COM | 462222100 | 1,331 | 57,140 | SH | | SOLE | | 57,140 | 0 | 0 |
Juno Therapeutics, Inc. | COM | 48205A109 | 3,075 | 80,000 | SH | | SOLE | | 80,000 | 0 | 0 |
Karyopharm Therapeutics Inc. | COM | 48576U106 | 1,456 | 216,990 | SH | | SOLE | | 216,990 | 0 | 0 |
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 220 | 13,746 | SH | | SOLE | | 13,746 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 8,753 | 73,386 | SH | | SOLE | | 73,386 | 0 | 0 |
Loxo Oncology, Inc. | COM | 548862101 | 3,193 | 137,735 | SH | | SOLE | | 137,735 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 9,816 | 363,676 | SH | | SOLE | | 363,676 | 0 | 0 |
Mast Therapeutics, Inc. | COM | 576314108 | 1,818 | 3,868,026 | SH | | SOLE | | 3,868,026 | 0 | 0 |
Medgenics, Inc. | COM NEW | 58436Q203 | 4,887 | 880,539 | SH | | SOLE | | 880,539 | 0 | 0 |
Medivation, Inc. | COM | 58501N101 | 19,892 | 329,876 | SH | | SOLE | | 329,876 | 0 | 0 |
MediWound Ltd. | ORD SHS | M68830104 | 1,783 | 226,000 | SH | | SOLE | | 226,000 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 8,972 | 1,122,859 | SH | | SOLE | | 1,122,859 | 0 | 0 |
Minerva Neurosciences, Inc. | COM | 603380106 | 5,191 | 508,405 | SH | | SOLE | | 508,405 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 12,390 | 2,269,198 | SH | | SOLE | | 2,269,198 | 0 | 0 |
Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | 2,625 | 350,000 | SH | | SOLE | | 35,000 | 0 | 0 |
Natera, Inc. | COM | 632307104 | 5,429 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 40,697 | 895,422 | SH | | SOLE | | 895,422 | 0 | 0 |
NeuroDerm Ltd. | ORD SHS | M74231107 | 4,956 | 305,000 | SH | | SOLE | | 305,000 | 0 | 0 |
Novavax, Inc. | COM | 670002104 | 17,297 | 2,379,254 | SH | | SOLE | | 2,379,254 | 0 | 0 |
Ophthotech Corporation | COM | 683745103 | 1,819 | 35,649 | SH | | SOLE | | 35,649 | 0 | 0 |
Osiris Therapeutics, Inc. | COM | 68827R108 | 2,541 | 499,193 | SH | | SOLE | | 499,193 | 0 | 0 |
Palatin Technologies, Inc. | COM PAR $.01 | 696077403 | 905 | 2,050,000 | SH | | SOLE | | 2,050,000 | 0 | 0 |
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 16,754 | 3,970,250 | SH | | SOLE | | 3,970,250 | 0 | 0 |
ProNAi Therapeutics, Inc. | COM | 74346L101 | 398 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
ProQR Therapeutics N.V. | SHS EURO | N71542109 | 5,973 | 1,234,095 | SH | | SOLE | | 1,234,095 | 0 | 0 |
Proteon Therapeutics, Inc. | COM | 74371L109 | 2,398 | 298,591 | SH | | SOLE | | 298,591 | 0 | 0 |
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 612 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Sage Therapeutics, Inc. | COM | 78667J108 | 6,751 | 224,048 | SH | | SOLE | | 224,048 | 0 | 0 |
Sangamo BioSciences, Inc. | COM | 800677106 | 23,484 | 4,055,876 | SH | | SOLE | | 4,055,876 | 0 | 0 |
SCYNEXIS, Inc. | COM | 811292101 | 1,015 | 467,600 | SH | | SOLE | | 467,600 | 0 | 0 |
Seattle Genetics, Inc. | COM | 812578102 | 1,747,287 | 43,238,967 | SH | | SOLE | | 43,238,967 | 0 | 0 |
Selecta Biosciences, Inc. | COM | 816212104 | 2,504 | 178,950 | SH | | SOLE | | 178,950 | 0 | 0 |
Seres Therapeutics, Inc. | COM | 81750R102 | 3,631 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Spark Therapeutics, Inc. | COM | 84652J103 | 67,407 | 1,318,341 | SH | | SOLE | | 1,318,341 | 0 | 0 |
Stemline Therapeutics, Inc. | COM | 85858C107 | 2,258 | 333,497 | SH | | SOLE | | 333,497 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM NEW | 867328601 | 2,437 | 4,450,000 | SH | | SOLE | | 4,450,000 | 0 | 0 |
Synta Pharmaceuticals Corp. | COM | 87162T206 | 526 | 2,021,728 | SH | | SOLE | | 2,021,728 | 0 | 0 |
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 3,711 | 204,465 | SH | | SOLE | | 204,465 | 0 | 0 |
Tenax Therapeutics, Inc. | COM | 88032L100 | 1,075 | 420,000 | SH | | SOLE | | 420,000 | 0 | 0 |
TG Therapeutics, Inc. | COM | 88322Q108 | 12,144 | 2,003,991 | SH | | SOLE | | 2,003,991 | 0 | 0 |
Trevena, Inc. | COM | 89532E109 | 2,835 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 1,902 | 211,792 | SH | | SOLE | | 211,792 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 5,424 | 110,894 | SH | | SOLE | | 110,894 | 0 | 0 |
uniQure N.V. | SHS | N90064101 | 1,695 | 230,000 | SH | | SOLE | | 230,000 | 0 | 0 |
Versartis, Inc. | COM | 92529L102 | 30,121 | 2,723,399 | SH | | SOLE | | 2,723,399 | 0 | 0 |
Vitae Pharmaceuticals, Inc. | COM | 92847N103 | 6,880 | 637,597 | SH | | SOLE | | 637,597 | 0 | 0 |
Windtree Therapeutics, Inc. | COM PAR | 97382D105 | 492 | 254,973 | SH | | SOLE | | 254,973 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 16,561 | 872,072 | SH | | SOLE | | 872,072 | 0 | 0 |
XenoPort, Inc. | COM | 98411C100 | 24,469 | 3,475,672 | SH | | SOLE | | 3,475,672 | 0 | 0 |
Zogenix, Inc. | COM NEW | 98978L204 | 8,050 | 1,000,000 | SH | | SOLE | | 1,000,000 | 0 | 0 |
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | NOTE 1.75% 6/15/2021 | 00484MAA4 | 67,351 | 77,083,000 | PRN | | SOLE | | 77,083,000 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | NOTE 2.0% 8/15/2019 | 00767EAB8 | 14,840 | 26,517,000 | PRN | | SOLE | | 26,517,000 | 0 | 0 |
Array BioPharma Inc. Notes 3.0% 6/1/2020 | NOTE 3.0% 6/1/2020 | 04269XAA3 | 2,544 | 3,000,000 | PRN | | SOLE | | 3,000,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | NOTE 1.875% 4/23/2017 | 09061GAD3 | 84,908 | 22,379,000 | PRN | | SOLE | | 22,379,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | NOTE 0.75% 10/15/2018 | 09061GAE1 | 13,573 | 12,228,000 | PRN | | SOLE | | 12,228,000 | 0 | 0 |
Clovis Oncology, Inc. 2.5% 9/15/2021 | NOTE 2.5% 9/15/2021 | 189464AB6 | 51,310 | 72,758,000 | PRN | | SOLE | | 72,758,000 | 0 | 0 |
Corsicanto Ltd. 3.5% 1/15/2032 | NOTE 3.5% 1/15/2032 | 220480AB3 | 15,285 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |
Exelixis, Inc. Notes 4.25% 8/15/2019 | NOTE 4.25% 8/15/2019 | 30161QAC8 | 29,654 | 20,000,000 | PRN | | SOLE | | 20,000,000 | 0 | 0 |
Incyte Corporation Notes 0.375% 11/15/2018 144A | NOTE 0.375% 11/15/2018 | 45337CAK8 | 431,835 | 259,000,000 | PRN | | SOLE | | 259,000,000 | 0 | 0 |
Incyte Corporation Notes 1.25% 11/15/2020 144A | NOTE 1.25% 11/15/2020 | 45337CAL6 | 467,293 | 274,500,000 | PRN | | SOLE | | 274,500,000 | 0 | 0 |
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | NOTE 4.5% 9/15/2018 | 74365AAB7 | 2,300 | 3,423,000 | PRN | | SOLE | | 3,423,000 | 0 | 0 |
XenoPort, Inc. Notes 2.5% 2/1/2022 | NOTE 2.5% 2/1/2022 | 98411CAB6 | 98,471 | 100,000,000 | PRN | | SOLE | | 100,000,000 | 0 | 0 |